Best AI tools for< Cancer Researcher >

The National Cancer Institute's Center for Biomedical Informatics and Information Technology (CBIIT) provides a comprehensive suite of tools, resources, and training to support cancer data science research. These resources include data repositories, analytical tools, data standards, and training materials. CBIIT also develops and maintains the NCI Thesaurus, a comprehensive vocabulary of cancer-related terms, and the Cancer Data Standards Registry and Repository (caDSR), a repository of cancer data standards. CBIIT's mission is to accelerate the pace of cancer research by providing researchers with the tools and resources they need to access, analyze, and share cancer data.

Galleri is a multi-cancer early detection test that uses a single blood draw to screen for over 50 types of cancer. It is recommended for adults aged 50 or older who are at an elevated risk for cancer. Galleri is not a diagnostic test and does not detect all cancers. A positive result requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.

Lunit Inc. is a leading provider of AI-powered cancer screening and treatment solutions. The company's mission is to conquer cancer through AI by developing innovative technologies that can help detect and treat cancer earlier and more effectively. Lunit's AI solutions are used by hospitals and clinics around the world to improve the accuracy and efficiency of cancer diagnosis and treatment.

iCAD is an AI-powered application designed for cancer detection, specifically focusing on breast cancer. The platform offers a suite of solutions including Detection, Density Assessment, and Risk Evaluation, all backed by science, clinical evidence, and proven patient outcomes. iCAD's AI-powered solutions aim to expose the hiding place of cancer, providing certainty and peace of mind, ultimately improving patient outcomes and saving more lives.

Oncora Medical is a healthcare technology company that provides software and data solutions to oncologists and cancer centers. Their products are designed to improve patient care, reduce clinician burnout, and accelerate clinical discoveries. Oncora's flagship product, Oncora Patient Care, is a modern, intelligent user interface for oncologists that simplifies workflow, reduces documentation burden, and optimizes treatment decision making. Oncora Analytics is an adaptive visual and backend software platform for regulatory-grade real world data analytics. Oncora Registry is a platform to capture and report quality data, treatment data, and outcomes data in the oncology space.

BetterMedicine is an AI software designed for cancer diagnostics and detection. It offers AI-powered solutions to enhance patient outcomes and drive efficiency in radiology workflows. The software is expertly designed by medical professionals and AI specialists, providing trusted and clinically validated solutions. BetterMedicine aims to address inefficiencies in radiology by integrating AI-powered software for detecting lesions on CT scans seamlessly into the workflow, thereby improving efficiency and reducing the risk of oversight. The application focuses on improving patient outcomes, reducing errors, and enhancing the wellbeing of radiology professionals.

Oatmeal Health is an AI-powered lung cancer screening and diagnosis platform designed to help Federally Qualified Health Centers (FQHCs) identify high-risk patients, provide reimbursed lung cancer screenings, and share revenue without increasing the clinical team's workload. The platform uses AI-driven patient identification, virtual NPs and AI for screening and navigation, shared reimbursement revenue model, and research-backed innovation to advance early detection tools. Oatmeal Health aims to improve patient engagement, clinical efficiency, quality, compliance, and revenue impact for FQHCs, all at no cost implementation.

SkinVision is a mobile application designed for accurate skin cancer detection. It connects users with dermatologists and insurers to optimize skin health. With over 3 million users, SkinVision offers clinically validated accuracy using advanced AI technology and oversight from dermatologists. Users can receive clear insights on their skin health, empowering them to take proactive steps. The app is praised for its ease of use and real people behind its development.

Evaxion is a pioneering TechBio company utilizing their AI-Immunology™ platform to decode the human immune system and develop novel vaccines for cancer and infectious diseases. Their platform accelerates vaccine target discovery, design, and development by simulating the human immune system and generating predictive models. Evaxion's cutting-edge research and multidisciplinary capabilities enable the rapid development of transformative treatments. The company aims to revolutionize the prevention and treatment of diseases through personalized and precision vaccines.

Nucleai is an AI-driven spatial biomarker analysis tool that leverages military intelligence-grade geospatial AI methods to analyze complex cellular interactions in a patient's biopsy. The platform offers a first-of-its-kind multimodal solution by ingesting images from various modalities and delivering actionable insights to optimize biomarker scoring, predict response to therapy, and revolutionize disease diagnosis and treatment.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Skinive is an AI-powered dermatology app that provides users with a personalized skin analysis and treatment plan. The app uses a combination of computer vision and machine learning to identify and track skin conditions, such as acne, rosacea, and skin cancer. Skinive also offers a variety of features to help users improve their skin health, such as a personalized skincare routine, a skin diary, and access to a team of dermatologists. Skinive is available as a mobile app and a web app.

Oncora Medical is an AI-powered platform that revolutionizes oncology care management. The platform offers a Clinical Data Platform for automating document generation and enhancing registry informatics. It provides AI-enabled case findings, revenue cycle management solutions, and cancer registry automation. Oncora's comprehensive AI solutions streamline workflows, improve outcomes, and capture revenue through intelligent automation. Trusted by top healthcare organizations worldwide, Oncora empowers healthcare organizations to achieve remarkable results in oncology care.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health. The platform is trusted by partners in precision health and medicine and is continuously evolving to disrupt drug discovery times and costs at all stages.

UXSquid is a comprehensive UX research software platform and tool that guides users through the user research process with interview question examples, plans, templates, and a cheat sheet. It offers a free trial, requires no credit card, and allows users to cancel anytime. UXSquid's platform makes it easy to conduct user interviews and gather feedback. Users can use its automation tools to set up interviews with their target audience and gather valuable information. UXSquid analyzes user experiences and interactions with a company using cutting-edge artificial intelligence. It then makes important suggestions and enhancements to improve a product for its users.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it is more treatable and potentially curable. GRAIL's Galleri® test is a first-of-its-kind multi-cancer early detection (MCED) test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps.

Paige is a leading AI company revolutionizing pathology with next-generation technology. They provide diagnostic and biomarker AI, predictive analytics technology, and AI-assisted applications to support cancer detection, subtyping, and molecular biomarker discovery from tissue samples. Paige offers a range of AI suites for prostate, breast, colon, and PanCancer, as well as the innovative Paige Alba™ multi-modal co-pilot. Their advanced AI technology and services help streamline AI development, optimize existing applications, and drive groundbreaking advancements in cancer care.

Expert in cancer biology

Medical expert on endometrial cancer, providing detailed and informative responses.

Provides medically-informed insights on breast cancer.

Compassionate support and information on cancer care.

Eradicate Cervical Cancer by Providing Trustworthy Information on HPV

Medical and informative guide on liver cancer.

A medically informative guide on bladder cancer.

Provides information on digestive health and stomach issues, in an informative tone.

Informative guide on lymphoma, covering classification and treatments.

Medical expert on melanoma, informative and detailed.

Expert in SCLC research, focused on a specific paper and broader SCLC knowledge.

Optimistic AI offering hopeful guidance on astrocytomas.

Expert in oncology trial matching, leveraging advanced GPT-4 Turbo techniques.

Find active recruiting oncology clinical trials near you.

Provides information on thyroid cancer.

Expert in PET/CT imaging, focusing on oncology, cardiology, neurology

Expert on radiation science and its medical applications

Stop paying for stuff you don't need

A helpful guide for Nohara Craft reservations.